Global survey on pancreatic surgery during the COVID-19 pandemic

• Verfasst von: Oba, Atsushi [VerfasserIn]
• Verfasst von: Stoop, Thomas F. [VerfasserIn]
• Verfasst von: Löhr, J.-Matthias [VerfasserIn]
• Verfasst von: Hackert, Thilo [VerfasserIn]
• Verfasst von: Zyromski, Nicholas [VerfasserIn]
• Verfasst von: Nealon, William H. [VerfasserIn]
• Verfasst von: Unno, Michiaki [VerfasserIn]
• Verfasst von: Schulick, Richard D. [VerfasserIn]
• Verfasst von: Al-Musawi, Mohammed H. [VerfasserIn]
• Verfasst von: Wu, Wenming [VerfasserIn]
• Verfasst von: Zhao, Yupei [VerfasserIn]
• Verfasst von: Satoi, Sohei [VerfasserIn]
• Verfasst von: Wolfgang, Christopher L. [VerfasserIn]
• Verfasst von: Abu Hilal, Mohammad [VerfasserIn]
• Verfasst von: Besselink, Marc G. [VerfasserIn]
• Verfasst von: Del Chiaro, Marco [VerfasserIn]
• Titel: Global survey on pancreatic surgery during the COVID-19 pandemic
• Verf.angabe: Atsushi Oba, Thomas F. Stoop, Matthias Löhr, Thilo Hackert, Nicholas Zyromski, William H. Nealon, Michiaki Unno, Richard D. Schulick, Mohammed H. Al-Musawi, Wenming Wu, Yupei Zhao, Sohei Satoi, Christopher L. Wolfgang, Mohammad Abu Hilal, Marc G. Besselink, and Marco Del Chiaro, on behalf of the Pancreas Club, European Pancreatic Club,Chinese Pancreatic Surgery Association, European Consortium on Minimally Invasive Pancreatic Surgery, Study Group of Preoperative Therapy for Pancreatic Cancer, Study Group of Pancreatic Ductal Adenocarcinoma withPeritoneal Metastasis and International Study Group on Cystic Tumors of the Pancreas
• E-Jahr: 2020
• Jahr: [August 2020]
• Umfang: 7 S.
• Illustrationen: 1 Diagramm
• Fussnoten: Gesehen am 29.09.2020
• Titel Quelle: Enthalten in: Annals of surgery
• Ort Quelle: [S.l.] : Lippincott Williams & Wilkins, 1885
• Jahr Quelle: 2020
• Band/Heft Quelle: 272(2020,2) Artikel-Nummer e87, 7 Seiten
• ISSN Quelle: 1528-1140
• DOI: doi:10.1097/SLA.0000000000004006
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1733901949

Abstract

Objective: - The aim of this study was to clarify the role of pancreatic surgery during the COVID-19 pandemic to optimize patients’ and clinicians’ safety and safeguard health care capacity. - Summary Background Data: - The COVID-19 pandemic heavily impacts health care systems worldwide. Cancer patients appear to have an increased risk for adverse events when infected by COVID-19, but the inability to receive oncological care seems may be an even larger threat, particularly in case of pancreatic cancer. - Methods: - An online survey was submitted to all members of seven international pancreatic associations and study groups, investigating the impact of the COVID-19 pandemic on pancreatic surgery using 21 statements (April, 2020). Consensus was defined as >80% agreement among respondents and moderate agreement as 60% to 80% agreement. - Results: - A total of 337 respondents from 267 centers and 37 countries spanning 5 continents completed the survey. Most respondents were surgeons (n = 302, 89.6%) and working in an academic center (n = 286, 84.9%). The majority of centers (n = 166, 62.2%) performed less pancreatic surgery because of the COVID-19 pandemic, reducing the weekly pancreatic resection rate from 3 [interquartile range (IQR) 2-5] to 1 (IQR 0-2) (P < 0.001). Most centers screened for COVID-19 before pancreatic surgery (n = 233, 87.3%). Consensus was reached on 13 statements and 5 statements achieved moderate agreement. - Conclusions: - This global survey elucidates the role of pancreatic surgery during the COVID-19 pandemic, regarding patient selection for the surgical and oncological treatment of pancreatic diseases to support clinical decision-making and creating a starting point for further discussion.